Purchase Order 15B50525P00000138
Award Date
9/12/25
Potential Completion Date
9/12/25
Potential Value
$22K
Federal Agency
Federal Medical Center Carswell
Awardee
Biologics, Inc.
Ultimate Awardee
Mckesson Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics to the agency in July 2025. The contract has no set-aside designation, indicating open competition. As a specialized pharmaceutical provider, Biologics, Inc. has a history of delivering critical medical treatments, particularly cancer medications, to...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics during fiscal year 2025. The contract has a ceiling value of $22,061.05 and an ultimate completion date of May 31, 2025. There is no set-aside designation for this contract, indicating open competition. Biologics, Inc. is a for-profit pharmaceutical company that specializes in...
This is a firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. for the provision of a cancer drug for new inmates. The contract, valued at $21,535.58, has an ultimate completion date of September 30, 2024. Biologics, Inc. is a for-profit organization that provides specialty pharmaceuticals to government agencies, including the Department of Veterans Affairs and the Bureau of Prisons. Biologics, Inc. is a subsidiary of the larger...
This federal contract award is for the delivery of cancer drugs and biologics to the Federal Medical Center Carswell, a civilian agency. The prime contractor is Biologics, Inc., a for-profit healthcare services and IT company that provides specialty pharmaceuticals to government agencies like the Department of Veterans Affairs and Bureau of Prisons. The contract has a ceiling value of $22,061.05 and is a firm fixed price purchase order with no set-aside designation. Biologics, Inc. is a...
This federal contract award was issued by the Veterans Integrated Service Network 21 to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The $77,455.83 firm fixed-price purchase order is for the supply of LENALIDOMIDE, a cancer medication, to federal healthcare and correctional facilities. The contract has an ultimate completion date of November 9, 2025 and was awarded on September 9, 2025. This award is part of Biologics, Inc.'s ongoing role in...
This is a $20,432.27 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the emergency procurement of the cancer medication Lenalidomide. The contract has an ultimate completion date of September 30, 2025 and was awarded on August 21, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. to provide the cancer drug TURALIO 125MG. The order is for delivery during Fiscal Year 2025 with a completion date of February 18, 2025 and a ceiling value of $22,061.05. Biologics, Inc. is a for-profit organization that has previously held federal contracts to supply specialty pharmaceuticals to agencies such as the Department of Veterans Affairs and the...
This federal contract award to Mckesson Corporation, a healthcare services and information technology company, is for the provision of DRUGS AND BIOLOGICALS. The $144,799.38 firm fixed-price delivery order was issued by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract does not have a set-aside designation. Mckesson has provided a range of pharmaceutical products and services, such as HIV medications, specialty...
This federal contract award is for a firm fixed price delivery order issued by the Department of Justice's Bureau of Prisons to Mckesson Corporation, a healthcare services and IT company that provides pharmaceuticals, medical supplies, and healthcare solutions to government agencies. The $18,490.73 contract is for FY25 pharmaceutical products and services, with an ultimate completion date of January 14, 2025. The award was not set aside for any specific business size or socioeconomic status....
This federal contract award is for the delivery of pharmaceutical products and medical supplies to various government agencies by Mckesson Corporation, a healthcare services and information technology company. The $1,316.47 firm fixed price purchase order was awarded on October 22, 2024 with a completion date of September 30, 2025. Mckesson is the prime contractor on this open market award, with no set-aside designation. The company has a history of providing pharmaceuticals, medical supplies,...